NL-OMON56304招募中不适用
The clinical validation of a dried blood spot method for immunosuppressive drugs and creatinine - VIDA study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- Aged 18 and over
- •- Able to understand written information and able to give informed consent
- •- Treated with tacrolimus, everolimus, sirolimus and/or ciclosporin
- •- Able and willing to undergo a finger prick for dried blood spot sampling
- •- Able and willing to fill in a questionnaire
排除标准
- •Unable to draw blood samples for study purposes
研究者
相似试验
招募中
不适用
The clinical validation of a dried blood spot method for vancomycin and creatinineconcentration of antibiotic in blood following infection10004018NL-OMON54384Erasmus MC, Universitair Medisch Centrum Rotterdam60
招募中
不适用
The clinical validation of a dried blood spot method for immunosuppressive drugs and creatinineTransplant recipientsNL-OMON23332one160
已完成
不适用
Clinical validation of the dried blood spot analysis for antituberculosis drugsBlood concentration of anti TB drugs10028440NL-OMON34891niversitair Medisch Centrum Groningen33
已完成
不适用
Clinical validation of a dried blood spot (DBS) method for the analysis of immunosuppressive and antifungal drugs in pediatric patients (part of the PROTECT study).immuunsuppressie na niertransplantatieanalysis of drug used in renal transplantation / analysis of drug used in invasive fungal infections10017528NL-OMON44369Afdeling Apotheek89
撤回
不适用
Clinical validation of a dried blood spot (DBS) method for the analysis of rifampicin (RIBOD study).analysis of drugs used for tuberculosis10004018NL-OMON42070niversitair Medisch Centrum Sint Radboud10